EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Literature-Guided 6-Gene Signature for the Stratification of High-Risk Acute Myeloid Leukemia

Jong Keon Song, Dong Hyeok Lee, Hyery Kim, Sang-Hyun Hwang

Cancer Research and Treatment · 2025

DOI: 10.4143/crt.2024.1114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Research and Treatment, 2025. Verfasst von Jong Keon Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Biomarkers, Tumor, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Acute myeloid leukemia (AML) shows significant heterogeneity in therapeutic responses. We aimed to develop a gene signature for the stratification of high-risk pediatric AML using publicly available AML datasets, with a focus on literature-based prognostic gene sets.Materials and Methods We identified 300 genes from 12 well-validated studies on AML-related gene signatures. Clinical and gene expression data were obtained from three datasets: TCGA-LAML, TARGET-AML, and BeatAML. Least absolute shrinkage and selection operator–Cox regression analysis was used to perform the initial gene selection and to construct a prognostic model using the The Cancer Genome Atlas (TCGA) database (n=132). The final gene signature was validated with two independent cohorts: BeatAML (n=411) and TARGET-AML (n=187).

Results

We identified a six-gene signature (ETFB, ARL6IP5, PTP4A3, CSK, HS3ST3B1, PLA2G4A), referred to as the literature-based signature 6 (LBS6), that was significantly associated with lower overall survival rates across the TCGA (high-risk [HR], 4.2; 95% confidence interval [CI], 2.59 to 6.81; p < 0.001), BeatAML (HR, 1.52; 95% CI, 1.17 to 1.96; p=0.001), and TARGET (HR, 2.05; 95% CI, 1.36 to 3.08; p < 0.001) datasets. The high-LBS6 score group exhibited significantly poorer five-year event-free survival compared to the low-LBS6 score group (HR, 2.09; 95% CI, 1.38 to 3.15; p < 0.001). After adjusting for key risk factors, including gene mutations (WT1, FLT3, and NPM1), protocol-based risk group, white blood cell count, and age, the LBS6 score was independently associated with worse survival rates in validation cohorts.

Conclusion

Our literature-driven approach identified a robust gene signature that stratifies AML patients into distinct risk groups. The LBS6 score shows promise in redefining initial risk stratification and identifying high-risk AML patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteBiomarkers, TumorTranscriptomeHumansPrognosisGene Expression ProfilingMaleFemaleChildAdolescentNucleophosminChild, PreschoolDatabases, Genetic

Stichwörter der Autor:innen

Acute myeloid leukemiaGene expression profilingLASSO-Cox regressionPediatricsPrognosis

Substanzen

Biomarkers, TumorNucleophosmin

Autor:innen und Institutionen

  • Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare
  • National Research Foundation of Korea
  • Ministry of Science and ICT

Zitieren

APA

Song, J. K., Lee, D. H., Kim, H., & Hwang, S. H. (2025). Literature-Guided 6-Gene Signature for the Stratification of High-Risk Acute Myeloid Leukemia. Cancer Research and Treatment. https://doi.org/10.4143/crt.2024.1114

Vancouver

Song JK, Lee DH, Kim H, Hwang SH. Literature-Guided 6-Gene Signature for the Stratification of High-Risk Acute Myeloid Leukemia. Cancer Research and Treatment. 2025. doi:10.4143/crt.2024.1114

BibTeX
@article{Song2025,
  author = {Song, Jong Keon and Lee, Dong Hyeok and Kim, Hyery and Hwang, Sang-Hyun},
  title = {Literature-Guided 6-Gene Signature for the Stratification of High-Risk Acute Myeloid Leukemia},
  journal = {Cancer Research and Treatment},
  year = {2025},
  doi = {10.4143/crt.2024.1114}
}
Kostenlos starten →